Related Experiment Videos
Plasma exchange for myasthenia gravis
1Intensive Care Unit, Raymond Poincare Hospital, AP-HP, 104, boulevard Raymond Poincaré, Garches, Ile de France, France, 92380. philippe.gajdos@rpc.ap-hop-paris.fr
The Cochrane Database of Systematic Reviews
|January 10, 2003
Summary
Plasma exchange shows short-term benefits for myasthenia gravis, particularly in crisis, but robust randomized trials are lacking. Further research is needed to confirm long-term efficacy and compare it with other treatments.
Area of Science:
- Neurology
- Immunology
- Clinical Trials
Background:
- Myasthenia gravis is an autoimmune disorder targeting acetylcholine receptors.
- Autoantibodies against nicotinic acetylcholine receptors cause neuromuscular transmission defects.
- Plasma exchange is a potential therapeutic intervention for myasthenia gravis.
Purpose of the Study:
- To evaluate the short-term and long-term effectiveness of plasma exchange in treating myasthenia gravis.
- To synthesize evidence from randomized controlled trials on plasma exchange for myasthenia gravis.
Main Methods:
- Searched Cochrane Neuromuscular Disease Group register and MEDLINE for randomized controlled trials (RCTs) up to June 2002.
- Included all randomized or quasi-randomized studies of patients with myasthenia gravis.
- Assessed outcomes including muscle score changes, functional scale improvements, ventilation weaning, remission rates, and adverse events.
Main Results:
- One RCT was identified, comparing plasma exchange with prednisone versus prednisone alone.
- No significant difference in muscle score improvement at one month was found between groups.
- Higher relapse rates were observed in the plasma exchange group during the first year; study limitations hinder definitive conclusions.
Conclusions:
- Adequate RCTs are lacking to confirm the efficacy of plasma exchange for myasthenia gravis.
- Case series suggest short-term benefits, especially in myasthenic crisis.
- Further research is required to establish long-term benefits and compare plasma exchange with alternative treatments.